# EDGAR Filing Document

**Accession Number:** 0000896747
**File Stem:** 0000000000-23-000401
**Filing Date:** 2023-1
**Character Count:** 2749
**Document Hash:** 5163c8a35187987646c731bb86992741
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-000401.hdr.sgml**: 20230217

**ACCESSION NUMBER**: 0000000000-23-000401

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230113

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AMERICAN BIO MEDICA CORP
- **CENTRAL INDEX KEY:** 0000896747
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 141702188
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 122 SMITH ROAD
- **CITY:** KINDERHOOK
- **STATE:** NY
- **ZIP:** 12106
- **BUSINESS PHONE:** 5187588158

**MAIL ADDRESS:**
- **STREET 1:** 122 SMITH ROAD
- **CITY:** KINDERHOOK
- **STATE:** NY
- **ZIP:** 12106

## Text-Extract

```

United States securities and exchange commission logo

                     January 13, 2023

       Melissa Waterhouse
       Chief Executive Officer
       American Bio Medica Corporation
       122 Smith Road
       Kinderhook, NY 12106

                                                        Re: American Bio Medica
Corporation
                                                            Preliminary Proxy
Statement on Schedule 14A
                                                            Filed December 22,
2022
                                                            File No. 000-28666

       Dear Melissa Waterhouse:

              We have completed our review of your filing. We remind you that
the company and its
       management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding
       any review, comments, action or absence of action by the staff.

                     Sincerely,

                     Division of Corporation Finance

                     Office of Life Sciences
       cc:                                              Spencer G. Feldman

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

January 13, 2023

Melissa Waterhouse
Chief Executive Officer
American Bio Medica Corporation
122 Smith Road
Kinderhook, NY 12106

Re: American Bio Medica Corporation
Preliminary Proxy Statement on Schedule 14A
Filed December 22, 2022
File No. 000-28666

Dear Melissa Waterhouse:

We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,

Division of Corporation Finance
Office of Life Sciences

cc: Spencer G. Feldman